Safety, Pharmacokinetics, and Pharmacodynamics of SHR7280, a Non-peptide GnRH Antagonist in Premenopausal Women with Endometriosis: A Randomized, Double-Blind, Placebo-Controlled Phase 1 Study

被引：0
|
作者：
Yuan Li
Ying Zheng
Bing Xu
Linrui Cai
Sheng Feng
Yiming Liu
Zhenyi Zhu
Qin Yu
Hongyan Guo
机构：
[1] Peking University Third Hospital,Department of Obstetrics and Gynecology
[2] Sichuan University,Department of Gynecologic Oncology, West China Second University Hospital
[3] Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University),National Drug Clinical Trial Institute, West China Second University Hospital
[4] Ministry of Education,Clinical Research and Development
[5] Sichuan University,undefined
[6] National Drug Clinical Trial Institution of West China Second Hospital,undefined
[7] NMPA Key Laboratory for Technical Resarch on Drug Products In Vitro and In Vivo Correlation,undefined
[8] Jiangsu Hengrui Pharmaceuticals Co.,undefined
[9] Ltd.,undefined
来源：
Clinical Pharmacokinetics | 2023年 / 62卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1739 / 1748
页数：9
相关论文
共 50 条
  • [41] Romosozumab in Postmenopausal Korean Women with Osteoporosis: A Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study
    Baek, Ki-Hyun
    Chung, Yoon-Sok
    Koh, Jung-Min
    Kim, In Joo
    Kim, Kyoung Min
    Min, Yong-Ki
    Park, Ki Deok
    Dinavahi, Rajani
    Maddox, Judy
    Yang, Wenjing
    Kim, Sooa
    Lee, Sang Jin
    Cho, Hyungjin
    Lim, Sung-Kil
    ENDOCRINOLOGY AND METABOLISM, 2021, 36 (01) : 60 - 69
  • [42] Efficacy and safety of soy isoflavone extract in postmenopausal women: A randomized, double-blind, and placebo-controlled study
    Nahas, Eliana Petri
    Nahas-Neto, Jorge
    Orsatti, Fabio Lera
    Carvalho, Eduardo Pessoa
    Uemura, Gilberto
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2007, 14 (06): : 1100 - 1100
  • [43] Safety and Pharmacokinetics of HRS-2261, a P2X3 Receptor Antagonist, in Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled Phase 1 Study
    Fan, Yuru
    Zhang, Xuan
    Zhang, Qin
    Zheng, Liang
    Zhou, Renpeng
    Sun, Cheng
    Wang, Xihan
    Song, Ke
    He, Zhusheng
    Wang, Honghui
    Zhang, Qian
    Hu, Wei
    CLINICAL PHARMACOKINETICS, 2024, 63 (03) : 293 - 302
  • [44] Pharmacokinetics and Safety Assessment of L-Tetrahydropalmatine in Cocaine Users: A Randomized, Double-Blind, Placebo-Controlled Study
    Hassan, Hazem E.
    Kelly, Deanna
    Honick, Moshe
    Shukla, Sagar
    Ibrahim, Ahmed
    Gorelick, David A.
    Glassman, Matthew
    McMahon, Robert P.
    Wehring, Heidi J.
    Kearns, Ann Marie
    Feldman, Stephanie
    Yu, Mingming
    Bauer, Ken
    Wang, Jia Bei
    JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 57 (02): : 151 - 160
  • [45] Safety and Pharmacokinetics of HRS-2261, a P2X3 Receptor Antagonist, in Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled Phase 1 Study
    Yuru Fan
    Xuan Zhang
    Qin Zhang
    Liang Zheng
    Renpeng Zhou
    Cheng Sun
    Xihan Wang
    Ke Song
    Zhusheng He
    Honghui Wang
    Qian Zhang
    Wei Hu
    Clinical Pharmacokinetics, 2024, 63 : 293 - 302
  • [46] A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY, TOLERABILITY, EFFICACY, PHARMACOKINETICS AND PHARMACODYNAMICS OF NIPOCALIMAB (M281) IN ADULTS WITH GE
    Guptill, Jeffrey
    Antozzi, Carlo
    Bril, Vera
    Gamez, Josep
    Meuth, Sven
    Munoz Blanco, Jose Luis
    Nowak, Richard
    Quan, Dianna
    Sevilla, Teresa
    Szczudlik, Andrzej
    Hegarty, Brooke
    Jouvin, Marie-Helene
    Jin, Jim
    Arroyo, Santiago
    MUSCLE & NERVE, 2020, 62 : S88 - S88
  • [47] The Safety, Pharmacokinetics, Pharmacodynamics and Immunogenicity of Ebronucimab in Healthy Volunteers: Result From a Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Dose-Escalation Study
    Chen, Rui
    Tian, Zhuang
    Tang, Xiange
    Hu, Pei
    Wang, Lvya
    Xia, Yu
    Li, Baiyong
    Wang, Max
    Ni, Xiang
    Wang, Guoqin
    Zhang, Shuyang
    CIRCULATION, 2022, 146
  • [48] Results from a randomized, double-blind, placebo-controlled, phase 1 trial evaluating sebetralstat pharmacokinetics, pharmacodynamics, and safety/tolerability in healthy Japanese, Chinese, and white adults
    Hide, M.
    Iverson, M.
    Jhee, S.
    Hansen, E.
    Duckworth, E. J.
    Hampton, S. L.
    Yoon, E.
    Honda, D.
    ALLERGY, 2023, 78 : 29 - 29
  • [49] The effect of hormone therapy on serum melatonin concentrations in premenopausal and postmenopausal women: A randomized, double-blind, placebo-controlled study
    Toffol, Elena
    Kalleinen, Nea
    Haukka, Jari
    Vakkuri, Olli
    Partonen, Timo
    Polo-Kantola, Paivi
    MATURITAS, 2014, 77 (04) : 361 - 369
  • [50] GLANCE Results of a phase 2, randomized, double-blind, placebo-controlled study
    Goodman, A. D.
    Rossman, H.
    Bar-Or, A.
    Miller, A.
    Miller, D. H.
    Schmierer, K.
    Lublin, F.
    Khan, O.
    Bormann, N. M.
    Yang, M.
    Panzara, M. A.
    Sandrock, A. W.
    NEUROLOGY, 2009, 72 (09) : 806 - 812
12345